[{"address1": "2500 Westchester Ave.", "city": "Purchase", "state": "NY", "zip": "10577", "country": "United States", "phone": "412 481 2210", "website": "https://www.cogrx.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery and development of small molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its lead product candidate is CT1812, an orally delivered molecule modulator designed to penetrate the blood-brain barrier and bind selectively to the S2R complex, which is in Phase 2 clinical trial for the treatment of Alzheimer's disease, as well as geographic atrophy secondary to dry age-related macular degeneration and synucleinopathies, such as dementia with Lewy bodies. Cognition Therapeutics, Inc. was incorporated in 2007 and is based in Purchase, New York.", "fullTimeEmployees": 25, "companyOfficers": [{"maxAge": 1, "name": "Ms. Lisa  Ricciardi", "age": 64, "title": "CEO, President & Director", "yearBorn": 1960, "fiscalYear": 2024, "totalPay": 951736, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. John Brendan Doyle", "age": 47, "title": "Chief Financial Officer", "yearBorn": 1977, "fiscalYear": 2024, "totalPay": 619940, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Anthony O. Caggiano M.D., Ph.D.", "age": 54, "title": "Chief Medical Officer and Head of R&D", "yearBorn": 1970, "fiscalYear": 2024, "totalPay": 676372, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Steven A. Weissman Ph.D.", "title": "VP & Head of CMC", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Anita  Cornet", "title": "Head of Quality", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Bobby  Horn", "title": "Corporate Controller", "fiscalYear": 2024, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1735603200, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.54, "open": 1.4056, "dayLow": 1.402, "dayHigh": 1.59, "regularMarketPreviousClose": 1.54, "regularMarketOpen": 1.4056, "regularMarketDayLow": 1.402, "regularMarketDayHigh": 1.59, "payoutRatio": 0.0, "beta": 1.232, "forwardPE": -2.012987, "volume": 897503, "regularMarketVolume": 897503, "averageVolume": 3803831, "averageVolume10days": 1138080, "averageDailyVolume10Day": 1138080, "bid": 1.53, "ask": 1.58, "bidSize": 6, "askSize": 6, "marketCap": 136825088, "fiftyTwoWeekLow": 0.222, "fiftyTwoWeekHigh": 3.83, "allTimeHigh": 13.8, "allTimeLow": 0.222, "fiftyDayAverage": 1.7154, "twoHundredDayAverage": 0.920815, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 97871096, "profitMargins": 0.0, "floatShares": 81765797, "sharesOutstanding": 88274258, "sharesShort": 7408085, "sharesShortPriorMonth": 7136374, "sharesShortPreviousMonthDate": 1759190400, "dateShortInterest": 1761868800, "sharesPercentSharesOut": 0.083900005, "heldPercentInsiders": 0.00713, "heldPercentInstitutions": 0.20035, "shortRatio": 4.14, "shortPercentOfFloat": 0.0904, "impliedSharesOutstanding": 88274258, "bookValue": 0.414, "priceToBook": 3.743961, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1759190400, "netIncomeToCommon": -27986000, "trailingEps": -0.47, "forwardEps": -0.77, "enterpriseToEbitda": -2.185, "52WeekChange": 2.326134, "SandP52WeekChange": 0.14261019, "quoteType": "EQUITY", "currentPrice": 1.55, "targetHighPrice": 4.0, "targetLowPrice": 2.0, "targetMeanPrice": 3.25, "targetMedianPrice": 3.5, "recommendationMean": 1.0, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 4, "totalCash": 39334000, "totalCashPerShare": 0.446, "ebitda": -44802000, "totalDebt": 380000, "quickRatio": 6.197, "currentRatio": 6.445, "debtToEquity": 1.04, "returnOnAssets": -0.78992, "returnOnEquity": -1.09725, "freeCashflow": -30301000, "operatingCashflow": -29533000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "CGTX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "CLOSED", "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1633699800000, "cryptoTradeable": false, "regularMarketChangePercent": 0.64935, "regularMarketPrice": 1.55, "shortName": "Cognition Therapeutics, Inc.", "longName": "Cognition Therapeutics, Inc.", "corporateActions": [], "postMarketTime": 1763167380, "regularMarketTime": 1763154002, "exchange": "NCM", "messageBoardId": "finmb_39366358", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "postMarketChangePercent": -0.6322553, "postMarketPrice": 1.5402, "postMarketChange": -0.009799957, "regularMarketChange": 0.00999999, "regularMarketDayRange": "1.402 - 1.59", "fullExchangeName": "NasdaqCM", "averageDailyVolume3Month": 3803831, "fiftyTwoWeekLowChange": 1.328, "fiftyTwoWeekLowChangePercent": 5.9819818, "fiftyTwoWeekRange": "0.222 - 3.83", "fiftyTwoWeekHighChange": -2.28, "fiftyTwoWeekHighChangePercent": -0.59530026, "fiftyTwoWeekChangePercent": 232.6134, "earningsTimestampStart": 1762977600, "earningsTimestampEnd": 1762977600, "earningsCallTimestampStart": 1742472000, "earningsCallTimestampEnd": 1742472000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -0.47, "epsForward": -0.77, "epsCurrentYear": -0.4075, "priceEpsCurrentYear": -3.803681, "fiftyDayAverageChange": -0.16540003, "fiftyDayAverageChangePercent": -0.096420676, "twoHundredDayAverageChange": 0.62918496, "twoHundredDayAverageChangePercent": 0.6832914, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2021-10-08", "averageAnalystRating": "1.0 - Strong Buy", "displayName": "Cognition Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-11-15"}]